FNY Investment Advisers, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
FNY Investment Advisers, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$0500.0%0.00%
Q1 2019$050
-9.1%
0.00%
Q4 2018$055
+1000.0%
0.00%
Q3 2018$050.0%0.00%
Q2 2018$050.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders